Abstract CT032: A first-in-human phase III clinical trial assessing novel mRNA-lipoplex nanoparticles for potent cancer immunotherapy in patients with malignant melanoma von Jabulowsky, Robert A, Loquai, Carmen, Diken, Mustafa, Kranz, Lena M, Haas, Heinrich, Attig, Sebastian, Bidmon, Nicole, Buck, Janina, Derhovanessian, Evelyna, Diekmann, Jan, Fritz, Daniel, Jahndel, Veronika, Kemmer-Brueck, Alexandra, Kuehlcke, Klaus, Kuhn, Andreas N, Langguth, Peter, Luxemburger, Ulrich, Meng, Martin, Mueller, Felicitas, Rae, Richard, Sari, Fatih, Schwarck-Kokarakis, Doreen, Seck, Christine, Spie, Kristina, Witt, Meike, Hassel, Jessica C, Utikal, Jochen, Kaufmann, Roland, Kreiter, Sebastian, Huber, Christoph, Tuereci, Oezlem, Sahin, Ugur

Volltext